Precision radiation may better control spine tumors without extra risk
NCT ID NCT07656883
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests a highly targeted radiation technique called stereotactic body radiotherapy (SBRT) against standard radiotherapy for people whose cancer has spread to the spine but has not yet compressed the spinal cord. The goal is to see if SBRT can better prevent tumor growth and spinal cord complications while keeping side effects low. Participants receive either standard radiation or SBRT over five sessions, with close monitoring for safety and tumor control.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Stereotactic Body Radiotherapy (SBRT)
What this could lead to
If successful, this precise radiation approach could offer better long-term control of spinal tumors, reducing pain and preventing spinal cord compression.
What could go wrong
This is a mid-stage trial; the higher radiation dose may increase risk of vertebral fractures or spinal cord injury, and benefits over standard care are not yet proven.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPIDURITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHD Vendée
La Roche-sur-Yon, 85000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CLCC Ste Catherine - Institut du cancer Avignon/Provence
Avignon, 84918, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre Gillaume le Conquérant
Le Havre, 76600, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre Henri Becquerel
Rouen, 76038, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Chru Bretonneau
Tours, 37044, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Chu de Brest
Brest, 29200, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Clinique Saint Yves
Vannes, 56000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Clinique Victor Hugo
Le Mans, 72000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Clinique de la Côte d'Emeraude
St-Malo, 35400, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Clinique mutualiste de l'Estuaire
Saint-Nazaire, 44600, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Groupe Hospitalier Bretagne Sud (GHBS)
Lorient, 56322, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut de Cancerologie de L'Ouest
Angers, 49055, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut de Cancérologie Radiothérapie Bretillien (ICRB)
Rennes, 35760, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut de Cancérologie de l'Ouest
Saint-Herblain, 44805, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact